Epoetin alfa
Epoetin alfa (rINN) rekombinantni je ljudski eritropoietin, koji se proizvodi u CHO ćelijama.[1][2][3]
| Klinički podaci | |
|---|---|
| Prodajno ime | Epogen, Epogen (Amgen Inc.), Epogin (Chugai), Epomax (Elanex) |
| Drugs.com | alfa.html Monografija |
| Način primene | Subkutano, intravenozno |
| Identifikatori | |
| CAS broj | 113427-24-0  |
| ATC kod | B03XA02 (WHO), B03XA01 |
| DrugBank | DB00016 |
| ChEMBL | CHEMBL1201565 |
| Hemijski podaci | |
| Formula | C815H1317N233O241S5 |
| Molarna masa | 18396.1 |
| Fizički podaci | |
| Tačka topljenja | 53 °C (127 °F) |
Reference
uredi- ^ Walsh G, Spada S (2005). „Epogen/Procrit”. Directory of approved biopharmaceutical products. Boca Raton: CRC Press. стр. 39–41. ISBN 978-0-415-26368-9.
- ^ Knox C, Law V, Jewison T, Liu P, Ly S, Frolkis A, Pon A, Banco K, Mak C, Neveu V, Djoumbou Y, Eisner R, Guo AC, Wishart DS (2011). „DrugBank 3.0: a comprehensive resource for omics research on drugs”. Nucleic Acids Res. 39 (Database issue): D1035—41. PMC 3013709
. PMID 21059682. doi:10.1093/nar/gkq1126.
- ^ David S. Wishart; Craig Knox; An Chi Guo; Dean Cheng; Savita Shrivastava; Dan Tzur; Bijaya Gautam; Murtaza Hassanali (2008). „DrugBank: a knowledgebase for drugs, drug actions and drug targets”. Nucleic acids research. 36 (Database issue): D901—6. PMC 2238889 . PMID 18048412. doi:10.1093/nar/gkm958.
Literatura
uredi- Hardman JG, Limbird LE, Gilman AG (2001). Goodman & Gilman's The Pharmacological Basis of Therapeutics (10. изд.). New York: McGraw-Hill. ISBN 0071354697. doi:10.1036/0071422803.
- Thomas L. Lemke; David A. Williams, ур. (2007). Foye's Principles of Medicinal Chemistry (6. изд.). Baltimore: Lippincott Willams & Wilkins. ISBN 0781768799.
Spoljašnje veze
uredi | Molimo Vas, obratite pažnju na važno upozorenje u vezi sa temama iz oblasti medicine (zdravlja). |
